ILK and familial pancreatic carcinoma: Nevertheless, genetic knockdown or pharmacological inhibition of ILK caused depleted MUC1-C expression in IL-6-treated pancreatic cancer cells, indicating that ILK is required to sustain STAT3-induced MUC1 upregulation by maintaining its stability.